Digital Blood Pressure Monitor

K152415 · Suzhou Sunspirit Co., Ltd. · DXN · May 6, 2016 · Cardiovascular

Device Facts

• Record ID: K152415
• Device Name: Digital Blood Pressure Monitor
• Applicant: Suzhou Sunspirit Co., Ltd.
• Product Code: DXN · Cardiovascular
• Decision Date: May 6, 2016
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 870.1130
• Device Class: Class 2

Intended Use

Digital Blood Pressure Monitor is intended to be used as a medical assistant instrument at home or in a medical center for adult populations for measuring blood pressure and heart rate. The device is intended for using in only adult population, not applied to the other populations such as neonatal baby. It cannot be used while the wrist (arm) has bleeding or wound to avoid the blood flowing from the wound in pressurizing.

Device Story

Fully automatic non-invasive blood pressure monitor; uses oscillometric method via wrist-worn inflatable cuff. Built-in air pump inflates cuff at MCU-controlled constant rate; pressure oscillations detected during deflation. Device calculates systolic/diastolic blood pressure and heart rate; results displayed on LCD. Used at home or medical centers by adult patients. Provides objective blood pressure data to assist users in monitoring cardiovascular health; facilitates clinical decision-making by providing repeatable measurements.

Clinical Evidence

Clinical validation performed via comparison study against auscultatory method using trained observers. Study confirmed clinical repeatability is statistically and clinically acceptable. Device complies with ANSI/AAMI/ISO 81060-2:2009 and BS EN1060-4:2004 standards.

Technological Characteristics

Oscillometric measurement principle; built-in air pump; MCU-controlled inflation/deflation. Wrist-worn cuff. LCD display. Standards: IEC 80601-2-30, ANSI/AAMI/ISO 81060-2:2009, BS EN1060-4:2004, AAMI/ANSI ES 60601-1, IEC 60601-1-2.

Indications for Use

Indicated for adult population for non-invasive measurement of systolic/diastolic blood pressure and heart rate. Contraindicated for neonates and individuals with bleeding or wounds on the wrist/arm.

Regulatory Classification

Identification

A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.

Predicate Devices

• BP201 Wrist Blood Pressure Monitor (K083043)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or a stylized human figure, composed of three overlapping profiles.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

May 6, 2016

Suzhou Sunspirit Co., Ltd. % Long Yang COO Shenzhen Hlongmed Biotech Company Limited R150-08, East Building, Yihai Plaza, Chuangye Road, Nanshan District Shenzhen, 518054 CN

Re: K152415

Trade/Device Name: Digital Blood Pressure Monitor models JWS-1000. JWS-970. JWS-950, JWS-940, JWS-706, JWS-705, JWS-704, JWS- JWS-703, JWS-701, JWS-700, BC20, and BC40 Regulation Number: 21 CFR 870.1130 Regulation Name: Noninvasive Blood Pressure Measurement System Regulatory Class: Class II Product Code: DXN Dated: March 30, 2016 Received: April 5, 2016

Dear Long Yang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR

{1}------------------------------------------------

Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours. Shawn W. Forrest -S 2016.05.06 17:10:25 -04'00'

for

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

#### DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

## Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.

510(k) Number (if known) K152415

## Device Name Digital Blood Pressure Monitor Models: JWS Series, including: JWS-1000, JWS-970, JWS-950, JWS-706, JWS-705, JWS-703, JWS-703, JWS-703, JWS-701, JWS-700,JWS-600, BC20, BC40

Indications for Use (Describe)

It can be used as medical assistant instrument at home or in medical center for adult population for measuring systolic and diastolic blood pressure and heart rate.

The device is intended for use in only adult population, not applied to ther populations such as neonatal baby.

It can not be used while the wrist (arm) has bleeding or wound to avoid the blood flowing from the wound in pressurizing.

Type of Use (Select one or both, as applicable)

| Prescription Use (Part 21 CFR 801 Subpart D)

X Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

# 510(k) Summary

## Date Prepared: July 31, 2015

## 1. Submitter:

SUZHOU SUNSPIRIT CO., LTD.

No.72, Hengshan Rd., Suzhou New District, P. R. China, 215009 Establishment Registration Number: 3010271644 Contact Person: Ms. Jing Zhang (OA manager) Tel: [phone] Fax: [phone] E-mail: [e-mail]

# 2. Submission Correspondent

1) Ms. Jing Zhang (QA manager) SUZHOU SUNSPIRIT CO., LTD. No.72, Hengshan Rd., Suzhou New District, P. R. China, 215009 Tel: [phone] Fax: [phone] E-mail: jing.zhang(@ssmedical.com.cn

## 2) Mr. Long Yang (COO)

Shenzhen Hlongmed Biotech Company Limited R1508, East Building, Yihai Plaza, Chuangye Road, Nanshan District, Shenzhen, P.R. China Tel: [phone] Fax: [phone] E-mail: [e-mail]

# 3. Proposed Device Information:

Trade name: Digital Blood Pressure Monitor Model: JWS Series, including: JWS-1000, JWS-970, JWS-950, JWS-940, JWS-706, JWS-705, JWS-704, JWS-703, JWS-701, JWS-700, JWS-600, BC20, BC40

{4}------------------------------------------------

Common name: Digital Blood Pressure Monitor Classification name: Noninvasive Blood Pressure Measurement System Review Panel: Cardiovascular System Devices Panel (74) Product Code: DXN Regulation Class: II Regulation Number: 870.1130

# 4. Predicate Device Information:

Company Name: SHENZHEN KINGYIELD TECHNOLOGY CO., LTD. Device Name: BP201 Wrist Blood Pressure Monitor 510(k) number: K083043

# 5. Device Description:

Digital Blood Pressure Monitor is a fully automatic non-invasive blood pressure monitor which measures systolic and diastolic blood pressure and heart rate of adult population using the oscillometric method by inflating an inflatable cuff on the wrist. Digital Blood Pressure Monitor JWS-1000, JWS-970, JWS-950, JWS-940, JWS-706, JWS-705. JWS-704. JWS-703. JWS-701. JWS-700. JWS-600. BC20. BC40 have the same technology, main function, performance and intended use, and they are consistent in product structure and material.

# 6. Intended use:

Digital Blood Pressure Monitor is intended to be used as a medical assistant instrument at home or in a medical center for adult populations for measuring blood pressure and heart rate. The device is intended for using in only adult population, not applied to the other populations such as neonatal baby.

It cannot be used while the wrist (arm) has bleeding or wound to avoid the blood flowing from the wound in pressurizing.

# 7. Performance and Technological Characteristics:

# 7.1 Performance Summary

In terms of operating specification, Safety & EMC requirements, the device conform to

{5}------------------------------------------------

IEC80601-2-30: applicable standards including 2009 -+Amendment 1:2013, ANSI/AAMI/ISO 81060-2:2009、 BS EN1060-4: 2004, AAMI / ANSI ES 60601-1:2005/(R)2012 +A1: 2012 and C1:2009/(R)2012 and, a2:2010/(r)2012, IEC 60601-1-2 Edition 3: 2007-03, A comparison study with a device that uses auscultatory method used by trained observers was performed to validate the performance of Digital Blood Pressure Monitor. The comparison study demonstrated that the clinical repeatability of Digital Blood Pressure Monitor is statistically and clinically acceptable.

## 7.2 Technological Characteristics

Digital Blood Pressure Monitor uses an inflated cuff which is wrapped around the wrist. The cuff is inflated by a built-in air pump. The systolic and diastolic blood pressures are determined by Oscillometric method. The inflation rate is controlled by MCU at a constant rate. The user can release the cuff to stop measuring by pressing the "ON/OFF" button at any time while measuring. The measuring result is displayed in LCD.

#### 8. Substantial equivalence discussion

#### 8.1. About the non-clinical tests

Digital Blood Pressure Monitor has the same intended use, the same technological characteristics as the predicate device BP201, such as Measurement localization, Measuring parameters, Measurement range, Measurement Accuracy, Inflation, Deflation, Power source.

The main differences are the physical size, shape and weight, Memory space

Measurable circumference of wrist, Operate environment, Storage environment and there is no any new issue of safety and effectiveness.

So the non-clinical performance information demonstrates the equivalence of the non-clinical performance.

In a word, Digital Blood Pressure Monitor is equivalent to the predicate device for the non-clinical performance.

#### 8.2. About the clinical tests

The device complies with the ANSVAAMI/ISO 81060-2:2009 standard and BS

{6}------------------------------------------------

EN1060-4: 2004 in its entirety. Thus Digital Blood Pressure Monitor & the predicate device BP201 are substantially equivalent.

# 9. Conclusion

Digital Blood Pressure Monitor has the same intended use, the same technological characteristics as the predicate device BP201. Moreover, non-clinical testing & clinical testing contained in this submission demonstrated that any difference in their technological characteristics does not raise any new issues of safety and effectiveness.

In a word, Digital Blood Pressure Monitor is substantial equivalent to the predicate device BP201.